LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Home・Akciju saraksts・Cencora Inc

Cencora Inc

Slēgts

SektorsVeselības aprūpe

370.83 1.17

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

369.63

Max

373.91

Galvenie mērījumi
By Trading Economics
Ienākumi	906M 566M
Pārdošana	2.2B 86B
P/E Sektora vidējais	43.836 108.767
EPS	2.87
Dividenžu ienesīgums	0.62
Peļņas marža	0.659
Darbinieki	47,000
EBITDA	858M 1B

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+14.14% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	0.62% 2.21%
Nākamie ieņēmumi	2026. g. 6. maijs
Nākamais dividenžu datums	2026. g. 2. marts
Nākamais Ex dividenžu datums	2026. g. 15. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	482M 71B
Iepriekšējā atvēršanas cena	369.66
Iepriekšējā slēgšanas cena	370.83

Ziņu noskaņojums

By Acuity

34%

66%

80 / 352 Rangs Healthcare

Cencora Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 27. febr. 23:53 UTC

Karstas akcijas

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

2026. g. 27. febr. 22:23 UTC

Iegādes, apvienošanās, pārņemšana

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

2026. g. 27. febr. 17:55 UTC

Karstas akcijas

Toronto Stocks Decline, But Remain On Track for Weekly Gains

2026. g. 27. febr. 23:46 UTC

Iegādes, apvienošanās, pārņemšana

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

2026. g. 27. febr. 23:33 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

2026. g. 27. febr. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2026. g. 27. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 27. febr. 21:30 UTC

Peļņas

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

2026. g. 27. febr. 21:30 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

2026. g. 27. febr. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

2026. g. 27. febr. 21:17 UTC

Peļņas

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026. g. 27. febr. 21:10 UTC

Iegādes, apvienošanās, pārņemšana

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

2026. g. 27. febr. 21:09 UTC

Iegādes, apvienošanās, pārņemšana

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

2026. g. 27. febr. 21:00 UTC

Peļņas

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

2026. g. 27. febr. 20:31 UTC

Iegādes, apvienošanās, pārņemšana

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

2026. g. 27. febr. 20:24 UTC

Tirgus saruna

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

2026. g. 27. febr. 20:23 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

2026. g. 27. febr. 20:12 UTC

Tirgus saruna

Nike Seen With Further Challenges in China -- Market Talk

2026. g. 27. febr. 19:44 UTC

Tirgus saruna

Gold Caps Historic Month -- Market Talk

2026. g. 27. febr. 19:39 UTC

Peļņas

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026. g. 27. febr. 19:38 UTC

Peļņas

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

2026. g. 27. febr. 18:53 UTC

Iegādes, apvienošanās, pārņemšana

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

2026. g. 27. febr. 18:45 UTC

Peļņas

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

2026. g. 27. febr. 18:45 UTC

Tirgus saruna

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

2026. g. 27. febr. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 27. febr. 17:07 UTC

Peļņas

Pemex Cuts 4Q Loss As Operating Results Improve

2026. g. 27. febr. 17:00 UTC

Tirgus saruna

Corn Rides Oil Momentum Higher -- Market Talk

2026. g. 27. febr. 16:31 UTC

Tirgus saruna

Canadian Economy Shows Resilience -- Market Talk

2026. g. 27. febr. 16:17 UTC

Tirgus saruna

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

2026. g. 27. febr. 15:49 UTC

Peļņas

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Cencora Inc Prognoze

Cenas mērķis

By TipRanks

14.14% augšup

Prognoze 12 mēnešiem

Vidējais 418.5 USD 14.14%

Augstākais 440 USD

Zemākais 400 USD

Pamatojoties uz 9 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cencora Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

9 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 9 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Cencora Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

80 / 352 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.